**Author details**

Yogambha Ramaswamy1 , Khoon S Lim2 , Hala Zreiqat1 and Zufu Lu1\*

\*Address all correspondence to: zufu.lu@sydney.edu.au

1 Biomaterials and Tissue Engineering Research Unit, School of AMME, The University of Sydney, Sydney, Australia

2 Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Depart‐ ment of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago Christ‐ church, Christchurch, New Zealand

### **References**


[14] Gangji, V., V. De Maertelaer, and J.-P. Hauzeur, *Autologous bone marrow cell implanta‐ tion in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study*. Bone, 2011. 49(5): p. 1005–1009.

**References**

12/11/15

368 Advanced Techniques in Bone Regeneration

408.

6.

Central, 2011. 9(66): p. 1–28.

Cells International, 2015. 2015: p. 7.

cine, 2006. 1(3): p. 317–332.

4): p. 883–892.

1638.

p. 201–209.

[1] Australian Orthopedic Association, 2014. https://www.aoa.org.au/ accessed on

[2] Amini, A.R., C.T. Laurencin, and S.P. Nukavarapu, *Bone tissue engineering: recent advances and challenges*. Critical Reviews in Biomedical Engineering, 2012. 40(5): p. 363–

[3] Marino, J.T. and B.H. Ziran, *Use of solid and cancellous autologous bone graft for fractures*

[4] Dimitriou, R., et al., *Bone: regeneration current concepts and future directions*. BioMed

[5] Walmsley, G., et al., *Osteogenic differentiation of adipose-derived stromal cells: advance‐ ments and future directions for bone tissue engineering*. Science Proceedings, 2016. 3: p. 1–

[6] Tsuji, K. and S. Kitamura, *Trophic factors from tissue stem cells for renal regeneration*. Stem

[7] Barrère, F., C.A. van Blitterswijk, and K. de Groot, *Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics*. International Journal of Nanomedi‐

[8] Logar, D., et al., *Expression of bone resorption genes in osteoarthritis and in osteoporosis*.

[9] Nakamura, I., et al., *Involvement of αvβ3 integrins in osteoclast function*. Journal of Bone

[10] Deschaseaux, F., L. Sensébé, and D. Heymann, *Mechanisms of bone repair and regenera‐*

[11] Liu, X., et al., *Mesenchymal stem cells systemically injected into femoral marrow of dogs home to mandibular defectsto enhance new boneformation*. Tissue Engineering Part A, 2013. 20(3–

[12] Liebergall, M., et al., *Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study*. Molecular Therapy, 2013. 21(8): p. 1631–

[13] Mesimäki, K., et al., *Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells*. International Journal of Oral and Maxillofacial Surgery, 2009. 38(3):

Journal of Bone and Mineral Metabolism, 2007. 24(4): p. 219–225.

*tion*. Trends in Molecular Medicine, 2009. 15(9): p. 417–429.

and Mineral Metabolism, 2007. 25(6): p. 337–344.

*and nonunions*. Orthopedic Clinics of North America, 2010. 41(1): p. 15–26.


[43] Li, F., N. Whyte, and C. Niyibizi, *Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for para‐ crine activities in bone regeneration*. Biochemical and Biophysical Research Communica‐ tions, 2012. 426(4): p. 475–479.

[28] Murphy, M.B., K. Moncivais, and A.I. Caplan, *Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine*. Experimental & Molecular Medicine,

[29] Mirotsou, M., et al., *Paracrine mechanisms of stem cell reparative and regenerative actions in the heart*. Journal of Molecular and Cellular Cardiology, 2011. 50(2): p. 280–289.

[30] Cantaluppi, V., et al., *Rationale of mesenchymalstem cell therapy in kidney injury*. American

[31] Kuo, T.K., et al., *Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells*. Gastroenterology, 2008. 134(7): p. 2111–2121. e3.

[32] Gotts, J.E. and M.A. Matthay, *Mesenchymal stem cells and acute lung injury*. Critical Care

[33] Uccelli, A., et al., *Neuroprotective features of mesenchymal stem cells*. Best Practice &

[34] Nakanishi, C., et al., *Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells*. Biochemical and Biophysical Research Communications, 2008.

[35] Timmers, L., et al., *Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction*. Stem Cell Research, 2011. 6(3): p. 206–214.

[36] Waszak, P., et al., *Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats*. Stem Cells and Development, 2012.

[37] Du, Z., et al., *Mesenchymal stem cell–conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation*. Journal of Surgical Research, 2013.

[38] van Poll, D., et al., *Mesenchymal stem cell–derived molecules directly modulate hepatocellu‐ lar death and regeneration in vitro and in vivo*. Hepatology, 2008. 47(5): p. 1634–1643.

[39] van Koppen, A., et al., *Human embryonic mesenchymalstem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease*. PLoS One, 2012. 7(6):

[40] Sowa, Y., et al., *Adipose-derived stem cells produce factors enhancing peripheral nerve regeneration: influence of age and anatomic site of origin*. Stem Cells and Development, 2011.

[41] Yamada, S., et al., *Trophic effect of adipose tissue–derived stem cells on porcine islet cells*.

[42] Djouad, F., et al., *Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases*.

Journal of Surgical Research, 2014. 187(2): p. 667–672.

Nature Reviews Rheumatology, 2009. 5(7): p. 392–399.

Journal of Kidney Diseases, 2013. 61(2): p. 300–309.

Research Clinical Haematology, 2011. 24(1): p. 59–64.

2013. 45(11): p. e54.

370 Advanced Techniques in Bone Regeneration

Clinics, 2011. 27(3): p. 719–733.

374(1): p. 11–16.

21(15): p. 2789–2797.

183(2): p. 907–915.

21(11): p. 1852–1862.

p. e38746.


[74] Yamashita, J., et al., *Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors*. Nature, 2000. 408(6808): p. 92–96.

[58] Gattazzo, F., A. Urciuolo, and P. Bonaldo, *Extracellular matrix: a dynamic microenviron‐ ment for stem cell niche*. Biochimica et Biophysica Acta (BBA)-General Subjects, 2014.

[59] Nakayama, K.H., et al., *Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering*. Tissue Engineering Part A, 2010. 16(7): p. 2207–2216.

[60] Lutolf, M.P. and H.M. Blau, *Artificial stem cell niches*. Advanced Materials, 2009. 21(32–

[61] Nava , M.M., M.T. Raimondi, and R. Pietrabissa, *Controlling self-renewal and differentia‐ tion of stem cells via mechanical cues*. BioMedical Research International, 2012. 2012 p.

[62] Polisetti, N., et al., *Cell adhesion molecules and stem cell‐niche‐interactions in the limbal stem*

[63] Méndez-Ferrer, S., et al., *Mesenchymal and haematopoietic stem cells form a unique bone*

[64] Park, D., et al., *Endogenous bone marrow MSCs are dynamic, fate-restricted participants in*

[65] Calvi, L., et al., *Osteoblastic cells regulate the haematopoietic stem cell niche*. Nature, 2003.

[66] Zhang, J., et al., *Identification of the haematopoietic stem cell niche and control of the niche*

[67] Kumar, B., et al., *Exosome-mediated microenvironment dysregulation in leukemia*. Biochi‐ mica et Biophysica Acta (BBA)-Molecular Cell Research, 2016. 1863(3): p. 464–470.

[68] Kawaguchi, J., P.J. Mee, and A.G. Smith, *Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors*. Bone, 2005. 36(5): p. 758–769.

[69] Zhang, H., et al., *Biomimetic three-dimensional microenvironment for controlling stem cell*

[70] Reilly, G.C. and A.J. Engler, *Intrinsic extracellular matrix properties regulate stem cell*

[71] Liu, Z.J., Y. Zhuge, and O.C. Velazquez, *Trafficking and differentiation of mesenchymal*

[72] Arvidson, K., et al., *Bone regeneration and stem cells*. Journal of Cellular and Molecular

[73] Arshi, A., et al., *Rigid microenvironments promote cardiac differentiation of mouse and human embryonic stem cells*. Science and Technology of Advanced Materials, 2016.

*bone maintenance and regeneration*. Cell Stem Cell, 2012. 10(3): p. 259–272.

1840(8): p. 2506–2519.

372 Advanced Techniques in Bone Regeneration

33): p. 3255–3268.

425(6960): p. 841–846.

*cell niche*. Stem Cells, 2016. 34(1): p. 203–219.

*size*. Nature, 2003. 425(6960): p. 836–841.

*fate*. Interface Focus, 2011. 1: p. rsfs20110035.

Medicine, 2011. 15(4): p. 718–746.

*differentiation*. Journal of Biomechanics, 2010. 43(1): p. 55–62.

*stem cells*. Journal of Cellular Biochemistry, 2009. 106(6): p. 984–991.

*marrow niche*. Nature, 2010. 466(7308): p. 829–834.

797410.


[90] Jasaitis, A., et al., *E-Cadherin-dependent stimulation of traction force at focal adhesions via the Src and PI3K signaling pathways*. Biophysical Journal, 2012. 103(2): p. 175–184. [91] Arnsdorf, E.J., et al., *Mechanically induced osteogenic differentiation–the role of RhoA, ROCKII and cytoskeletal dynamics*. Journal of Cell Science, 2009. 122(4): p. 546–553. [92] Sun, Y., C.S. Chen, and J. Fu, *Forcing stem cells to behave: a biophysical perspective of the*

[93] Shin, J.-W. and D.J. Mooney, *Improving stem cell therapeutics with mechanobiology*. Cell

[94] Ivanovska, I.L., et al., *Stem cell mechanobiology: diverse lessons from bone marrow*. Trends

[95] Dupont, S., et al., *Role of YAP/TAZ in mechanotransduction*. Nature, 2011. 474(7350): p.

[96] Halder, G., S. Dupont, and S. Piccolo, *Transduction of mechanical and cytoskeletal cues by YAP and TAZ*. Nature Reviews Molecular Cell Biology, 2012. 13(9): p. 591–600. [97] Abdeen, A.A., et al., *Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells*. Tissue Engineering Part A, 2014. 20(19–20): p. 2737–2745. [98] Jose, S., et al., *Enhanced trophic factor secretion by mesenchymal stem/stromal cells with glycine-histidine-lysine (GHK)-modified alginate hydrogels*. Acta Biomaterialia, 2014. 10(5):

[99] Silva, N.A., et al., *Modulation of bone marrow mesenchymal stem cell secretome by ECM-like*

[100] Hoch, A.I., et al., *Cell-secreted matrices perpetuate the bone-forming phenotype of differenti‐*

[101] Lu, Z., et al., *Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adiposetissue-derived mesenchymalstem cellsinto osteogenic differentiation*. Stem Cells

[102] Czekanska, E.M., et al., *Enhancing inflammatory and chemotactic signals to regulate bone*

[103] Crowder, S.W., et al., *Material cues as potent regulators of epigenetics and stem cell function*.

*cellular microenvironment*. Annual Review of Biophysics, 2012. 41: p. 519.

Stem Cell, 2016. 18(1): p. 16–19.

179–183.

374 Advanced Techniques in Bone Regeneration

p. 1955–1964.

in Cell Biology, 2015. 25(9): p. 523–532.

*hydrogels*. Biochimie, 2013. 95(12): p. 2314–2319.

and Development, 2012. 21(13): p. 2420–2429.

Cell Stem Cell, 2016. 18(1): p. 39–52.

*ated mesenchymal stem cells*. Biomaterials, 2016. 74: p. 178–187.

*regeneration*. European Cells & Materials, 2014. 28: p. 320–334.

*Edited by Alessandro Rozim Zorzi and Joao Batista de Miranda*

Advanced Techniques in Bone Regeneration is a book that brings together over 15 chapters, written by leading practitioners and researchers, of the latest advances in the area, including surgical techniques, new discoveries, and promising methods involving biomaterials and tissue engineering.

This book is intended for all who work in the treatment of disorders involving problems with the regeneration of bone tissue, are doctors or dentists, as well as are researchers and teachers involved in this exciting field of scientific knowledge.

Advanced Techniques in Bone Regeneration

Advanced Techniques in

Bone Regeneration

*Edited by Alessandro Rozim Zorzi* 

*and Joao Batista de Miranda*

Photo by eranicle / iStock